Home Latest Articles

Latest Articles

Latest Articles

ESMO 2020: First-in-class MK-4830 Antibody Targeting ILT4 Shows Promising Preliminary Results

Editorial Team - September 20, 2020

Featured image: Encouraging mother with breast cancer. 2018-2020 Fotolia/Adobe. used with permission.

Olema Oncology Expands Breast Cancer Development Following US $ 54 Million Series B Financing

Photo Courtesy: © 2020 Karius Inc.

Karius Secures US $165 M Series B Funding; Expands Access to its Microbial cell-free DNA technology

General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: Positive Results of Olaparib + Bevacizumab in Newly-Diagnosed Advanced Ovarian Cancer

Research Shows Molecular Engine That Drives Pancreatic Cancer and Ways to Turn It Off

Researchers Find New Way to Treat Aggressive form of Brain Tumor

Peter Hofland, Ph.D - August 21, 2019

US FDA to Review Isatuximab as a Potential Treatment for R/R...

Peter Hofland, Ph.D - July 10, 2019

Nutritionist meeting a patient.

While Oncologists? Pay Attention to Patients? Weight Management and Diet they...

Danielle Garcia - May 18, 2019

Daiichi Sankyo Accelerates Biologics License Application for Trastuzumab Deruxtecan

Peter Hofland, Ph.D - March 29, 2019

Oxybutynin Improved Quality of Life for Breast Cancer Survivors

Peter Hofland, Ph.D - December 8, 2018

Investigational Compound from Chinese Tree Bark Shows Potential as Treatment for...

Peter Hofland, Ph.D - November 7, 2018

Oral Sores and Cancer Treatment

Alisa Cooper Wechsler - May 11, 2018

First-line Treatment with Pembrolizumab

Peter Hofland, Ph.D - April 16, 2018

First Patients Enrolled in Landmark Lung Cancer Tri-Therapy Clinical Trial

Peter Hofland, Ph.D - January 19, 2018

Charitable Efforts Know No Boundaries When Helping the Underserved? Stakeholders Strive...

Eric T. Rosenthal - September 25, 2017

12 3 Page 1 of 3

LATEST NEWS

Japan Approves Cetuximab Saratolacan in Unresectable Locally Advanced/Recurrent Head & Neck Cancer

Peter Hofland, Ph.D - September 25, 2020

Astellas Establishes Global Patient-centricity Leadership: Includes Patient Perspective in Research

Peter Hofland, Ph.D - September 23, 2020

Lantern Pharma and Fox Chase Cancer Center Collaborate in Developing LP-184 in Pancreatic Cancer

Editorial Team - September 22, 2020

ESMO 2020: Tisotumab Vedotin Shows Meaningful Clinical Activity in Cervical Cancer

Peter Hofland, Ph.D - September 21, 2020

Black Women Experience Longer Waits and Less Timely Treatment for Breast Cancer

Peter Hofland, Ph.D - September 21, 2020

Press Releases | Cancer

Xstrahl Appoints Dr. Richard Shaffer as Medical Director September 24, 2020
Dr. Shaffer will help support the use of radiation therapy for skin cancer and benign disease(PRWeb September 24, 2020)Read the full story at https://www.prweb.com/releases/xstrahl_appoints_dr_richard_shaffer_as_medical_director/prweb17415571.htm
Uniform Advantage Donates $20,000 to the Breast Cancer Research... September 24, 2020
Uniform Advantage launches a breast cancer awareness campaign and donates $20,000 to the Breast Cancer Research Foundation in support of breast cancer research.(PRWeb September 24, 2020)Read the full story at https://www.prweb.com/releases/uniform_advantage_donates_20_000_to_the_breast_cancer_research_foundation_in_support_of_breast_cancer_research/prweb17419680.htm
The Tisch Cancer Institute Earns Second Consecutive Designation from... September 24, 2020
The Tisch Cancer Institute at Mount Sinai (TCI) has been awarded $13 million as part of the renewal of its National Cancer Institute Cancer Center Designation, a prestigious distinction that is based...(PRWeb September 24, 2020)Read the full story at https://www.prweb.com/releases/the_tisch_cancer_institute_earns_second_consecutive_designation_from_national_cancer_institute/prweb17422135.htm